ERRα is a marker of tamoxifen response and survival in triple-negative breast cancer

PURPOSE: Estrogen-related receptor alpha (ERRα) signaling has recently been implicated in breast cancer. We investigated the clinical value of ERRα in randomized cohorts of tamoxifen-treated and adjuvant-untreated patients. EXPERIMENTAL DESIGN: Cox proportional hazards regression was used to evaluat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cancer Res
Hlavní autoři: Manna, Subrata, Bostner, Josefine, Sun, Yang, Miller, Lance D., Alayev, Anya, Schwartz, Naomi S., Lager, Elin, Fornander, Tommy, Nordenskjöld, Bo, Yu, Jane J., Stål, Olle, Holz, Marina K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794381/
https://ncbi.nlm.nih.gov/pubmed/26542058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0857
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky